KP Tissue Inc. (TSE:KPT – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$11.88 and traded as high as C$12.80. KP Tissue shares last traded at C$12.75, with a volume of 5,022 shares traded.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on KPT shares. TD raised their price objective on KP Tissue from C$12.00 to C$14.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Desjardins boosted their target price on shares of KP Tissue from C$12.00 to C$12.50 and gave the stock a “hold” rating in a report on Friday, May 15th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of C$12.12.
View Our Latest Research Report on KP Tissue
KP Tissue Price Performance
KP Tissue (TSE:KPT – Get Free Report) last released its quarterly earnings results on Thursday, August 13th. The company reported C$0.24 earnings per share (EPS) for the quarter. On average, analysts expect that KP Tissue Inc. will post 0.4398964 EPS for the current year.
KP Tissue Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 15th were given a $0.21 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 6.6%. KP Tissue’s dividend payout ratio (DPR) is presently 85.23%.
Insiders Place Their Bets
In related news, Director David A. Spraley sold 3,668 shares of the business’s stock in a transaction on Wednesday, June 17th. The stock was sold at an average price of C$13.30, for a total transaction of C$48,784.40. Following the transaction, the director directly owned 15,712 shares in the company, valued at C$208,969.60. The trade was a 18.93% decrease in their position. In the last quarter, insiders sold 6,668 shares of company stock worth $87,644. 0.14% of the stock is owned by insiders.
About KP Tissue
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Featured Stories
- Five stocks we like better than KP Tissue
- 3 Low-P/E Stocks That Look Cheap as the S&P 500 Trades Near Record Highs
- Travel + Leisure Goes Big—Is It Ready to Rally?
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
